Interleukin Genetics, Inc.
Interleukin Genetics Reports Third Quarter 2008 Financial Results
Published in Physician Business Week, November 25th, 2008
The Company reported a net loss of $1.6 million, or $(.05) per basic and diluted common share, for the third quarter of 2008 compared to a net loss of $1.1 million, or $(.04) per basic and diluted common share, for the same period last year.
"Collaborations are an important element of Interleukin Genetics' strategic plan to distribute and develop new, high value genetic tests, and we were pleased to lay significant groundwork for new partnerships this quarter," commented Lewis H. Bender, Chief Executive Officer. "Our revised...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Business Week
More Articles from Physician Business Week
- Anesthesia
Team Finance LLC Announces Third Quarter 2008 Results - Aspyra, Inc.
Aspyra to Unveil New Volume-Based PACS and RIS/PACS Pricing at RSNA 2008 - Cancer
Oslo and Toulouse Cancer Clusters Join Forces to Drive European Cancer Research Forward - EagleBank Foundation
Fourth Annual EagleBank Foundation Fight Breast Cancer Golf Classic Raises Over $100,000 - Integrated Healthcare Holdings, Inc.
Chief Executive Officer Leaving Integrated Healthcare Holdings, Inc. - Intelity
Intelity Introduces ICE, the Hotelier's Solution to Increase Revenue and Decrease Expenses While Maintaining Service - More from this issue of Physician Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
